Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro.

Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, Komaroff AL, Ambros PF, Medveczky PG.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8. doi: 10.1073/pnas.0913586107. Epub 2010 Mar 8.

2.
3.

Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.

Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.

Mod Pathol. 2003 Jul;16(7):708-15.

4.

Quality assessment of genetic markers used for therapy stratification.

Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, Couturier J, Darnfors C, Delattre O, Freeman-Edward J, Gambini C, Gross N, Hattinger CM, Luegmayr A, Lunec J, Martinsson T, Mazzocco K, Navarro S, Noguera R, O'Neill S, Potschger U, Rumpler S, Speleman F, Tonini GP, Valent A, Van Roy N, Amann G, De Bernardi B, Kogner P, Ladenstein R, Michon J, Pearson AD, Ambros PF.

J Clin Oncol. 2003 Jun 1;21(11):2077-84.

PMID:
12775732
5.

[Detection, quantification and characterization of disseminated tumor cells].

Ambros PF, Méhes G, Ambros IM, Luegmayr A, Ladenstein R, Gadner H.

Acta Med Austriaca Suppl. 2002;59:58-61. German.

PMID:
12506762
6.

Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.

Aryee DN, Ambros I, Ambros PF, Muehlbacher K, Luegmayr A, Yoshie O, Kovar H.

Pediatr Res. 2002 Aug;52(2):279-85.

PMID:
12149507
7.

Automatic detection and genetic profiling of disseminated neuroblastoma cells.

Méhes G, Luegmayr A, Hattinger CM, Lörch T, Ambros IM, Gadner H, Ambros PF.

Med Pediatr Oncol. 2001 Jan;36(1):205-9.

PMID:
11464886
8.

Neuroblastoma cells provoke Schwann cell proliferation in vitro.

Ambros IM, Attarbaschi A, Rumpler S, Luegmayr A, Turkof E, Gadner H, Ambros PF.

Med Pediatr Oncol. 2001 Jan;36(1):163-8.

PMID:
11464875
9.

Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.

Ambros PF, Ambros IM, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, Amann G, Kovar H, Horcher E, De Bernardi B, Michon J, Gadner H.

Med Pediatr Oncol. 2001 Jan;36(1):1-4.

PMID:
11464855
10.
11.

Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches--functional and prognostic information.

Ambros PF, Méhes G, Hattinger C, Ambros IM, Luegmayr A, Ladenstein R, Gadner H.

Leukemia. 2001 Feb;15(2):275-7. No abstract available.

12.

Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation--sign of tumour cell revertance?

Ambros IM, Rumpler S, Luegmayr A, Hattinger CM, Strehl S, Kovar H, Gadner H, Ambros PF.

Eur J Cancer. 1997 Oct;33(12):2043-9.

PMID:
9516850
13.

Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?

Ambros PF, Ambros IM, Strehl S, Bauer S, Luegmayr A, Kovar H, Ladenstein R, Fink FM, Horcher E, Printz G, et al.

Eur J Cancer. 1995;31A(4):510-5.

PMID:
7576955

Supplemental Content

Loading ...
Support Center